|
Proimmune
hbv-specific genotype d overlapping peptides (olps) ![]() Hbv Specific Genotype D Overlapping Peptides (Olps), supplied by Proimmune, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/olps/hbv+specific+genotype+d+overlapping+peptides++olps+/pmc09554084-61-4-6 Average 90 stars, based on 1 article reviews
hbv-specific genotype d overlapping peptides (olps) - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Proimmune
hbv core overlapping peptides (olps) genotype d ![]() Hbv Core Overlapping Peptides (Olps) Genotype D, supplied by Proimmune, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/olps/hbv+core+overlapping+peptides++olps++genotype+d/pmc06773856-106-26-30 Average 90 stars, based on 1 article reviews
hbv core overlapping peptides (olps) genotype d - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Dawley Inc
primary cultures of olps ![]() Primary Cultures Of Olps, supplied by Dawley Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/olps/primary+cultures+of+olps/pm27797401-39-4-8 Average 90 stars, based on 1 article reviews
primary cultures of olps - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Mimotopes
overlapping hcv peptides (olps) ![]() Overlapping Hcv Peptides (Olps), supplied by Mimotopes, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/olps/overlapping+hcv+peptides++olps+/pmc06886882-90-1-20 Average 90 stars, based on 1 article reviews
overlapping hcv peptides (olps) - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Genaxxon BioScience GmbH
overlapping peptides (olps) ![]() Overlapping Peptides (Olps), supplied by Genaxxon BioScience GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/olps/overlapping+peptides++olps+/pmc10019593__mmc1-5-17-62 Average 90 stars, based on 1 article reviews
overlapping peptides (olps) - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Mimotopes
overlapping hivp24 peptides (olps) ![]() Overlapping Hivp24 Peptides (Olps), supplied by Mimotopes, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/olps/hivp24+peptides++olps+/pmc04357381-52-2-36 Average 90 stars, based on 1 article reviews
overlapping hivp24 peptides (olps) - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
GenScript corporation
olps ![]() Olps, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/olps/olps/pm39972124-517-3-5 Average 90 stars, based on 1 article reviews
olps - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
The Company of Biologists
pdgfra-positive presumptive oligodendrocyte progenitors (olps) ![]() Pdgfra Positive Presumptive Oligodendrocyte Progenitors (Olps), supplied by The Company of Biologists, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/olps/pdgfra+positive+presumptive+oligodendrocyte+progenitors++olps+/pm11493571-6-11-39 Average 90 stars, based on 1 article reviews
pdgfra-positive presumptive oligodendrocyte progenitors (olps) - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
The Company of Biologists
olps ![]() Olps, supplied by The Company of Biologists, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/olps/olps/pm12399304-11-13-39 Average 90 stars, based on 1 article reviews
olps - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
GenScript corporation
11–15-mer synthetic olps corresponding to each 25-mer neoantigen vaccine peptide ![]() 11–15 Mer Synthetic Olps Corresponding To Each 25 Mer Neoantigen Vaccine Peptide, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/olps/11+15+mer+synthetic+olps+corresponding+to+each+25+mer+neoantigen+vaccine+peptide/pm40346292-211-9-12 Average 90 stars, based on 1 article reviews
11–15-mer synthetic olps corresponding to each 25-mer neoantigen vaccine peptide - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Gut
Article Title: Impact of HBsAg and HBcrAg levels on phenotype and function of HBV-specific T cells in patients with chronic hepatitis B virus infection
doi: 10.1136/gutjnl-2021-324646
Figure Lengend Snippet: HBV-specific CD4 + and CD8 + T cell responses in different age groups. HBV-specific CD4 + and CD8 + T cell responses following 10-day in vitro stimulation with HBV overlapping peptide (OLP) pools grouped according to the patients’ age. (A) Representative flow cytometry plots of HBV core-specific IFN-γ + /TNF + CD4 + T cell responses of two patients. (B) Heat map showing mean of frequencies of total cytokine + HBV-specific CD4 + and CD8 + T cells (age groups: 18–39, n=25; 40–49, n=17; ≥50, n=15). (C) IFN-γ + HBV-specific CD4 + and CD8 + T cells of different age groups. (D) Correlation analyses of age with frequencies of total IFN-γ + CD4 + and CD8 + T cells. (E) Mean percentages of multifunctional CD4 + and CD8 + T cell responses after in vitro expansion with total HBV OLPs (sum of 14 OLP pools). Statistical significance between each of the two groups was tested by Mann-Whitney test for non-parametric data and by unpaired t-test for parametric data (B–C). *p<0.05; **p<0.01. IFN, interferon; TNF, tumour necrosis factor.
Article Snippet: HBV-specific genotype D overlapping
Techniques: In Vitro, Flow Cytometry, MANN-WHITNEY
Journal: Methods in molecular biology (Clifton, N.J.)
Article Title: Determination of Hepatitis C Virus-Specific T-Cell Activity
doi: 10.1007/978-1-59745-394-3_30
Figure Lengend Snippet: Matrix approach for epitope mapping. In this case, each matrix pool (A to J and AA to JJ) consists of five HCV overlapping peptides. A specific peptide is included in only one of the horizontal matrix pools (A to J) and only one of the vertical matrix pools (AA to JJ). Therefore, if pools D and CC yield positive responses, peptide 24 triggered the response. If pools C, D, E, and CC induce formation of a significant number of spots in the ELISpot assay, the responsible epitope probably consists of the shared sequence of peptides 23, 24 and 25 (fcsamyvgdl).
Article Snippet: Overlapping
Techniques: Enzyme-linked Immunospot, Sequencing
Journal: PLoS ONE
Article Title: Clinical Outcome of HIV Viraemic Controllers and Noncontrollers with Normal CD4 Counts Is Exclusively Determined by Antigen-Specific CD8 + T-Cell-Mediated HIV Suppression
doi: 10.1371/journal.pone.0118871
Figure Lengend Snippet: (A) Breadth of T-cell responses against 23 HIVp24-specific OLPs from VC (N = 19, filled circle) and NC (N = 42, open rectangle) (B) Breadth of T-cell responses against HLA-B*57/B*58-restricted epitopes (N = 6) in HLA-B*57/B*58 positive VC (N = 5, filled circle) and NC (N = 9, open rectangle) (C) Cumulative magnitude of T-cell responses against 23 HIVp24-specific OLPs in VC (N = 19, filled circle) and NC (N = 42, open rectangle) (D) Cumulative magnitude of T-cell responses against HLA-B*57/B*58-restricted epitopes (N = 6) in HLA-B*57/B*58 positive VC (N = 5, filled circle) and NC (N = 9, open rectangle). (E and F) Correlation between breadth and cumulative magnitude of T-cell responses against HIVp24-specific OLPs and patient pVL were analyzed by using Spearman’s rank test.
Article Snippet: Twenty-three overlapping
Techniques:
Journal: PLoS ONE
Article Title: Clinical Outcome of HIV Viraemic Controllers and Noncontrollers with Normal CD4 Counts Is Exclusively Determined by Antigen-Specific CD8 + T-Cell-Mediated HIV Suppression
doi: 10.1371/journal.pone.0118871
Figure Lengend Snippet: (A) Functional quality of CD8 + T-cell responses against HIVp24-specific OLPs (N = 23) in VC (N = 18, filled circle) and NC (N = 31, open rectangle) (B) Functional quality of CD8 + T-cell responses against HLA-B*57/B*58-restricted HIVp24-specific epitopes (N = 6) in HLA-B*57/B*58 positive VC (N = 5, filled circle) and NC (N = 9, open rectangle). The Y-axis represents absolute CD8 + T cells and the X-axis represents CD8 + T cells with 5-, 4-, 3-, 2-, and 1-function in VC and NC. (C) The correlation between the absolute cell numbers of 5-functional HIVp24-specific CD8 + T cells and pVL was analysed using Spearman’s rank test.
Article Snippet: Twenty-three overlapping
Techniques: Functional Assay
Journal: PLoS ONE
Article Title: Clinical Outcome of HIV Viraemic Controllers and Noncontrollers with Normal CD4 Counts Is Exclusively Determined by Antigen-Specific CD8 + T-Cell-Mediated HIV Suppression
doi: 10.1371/journal.pone.0118871
Figure Lengend Snippet: (A) In vitro HIV suppression assay mediated by ex vivo unstimulated CD8 + T cells in VC (N = 10, filled circle), NC (N = 10, open rectangle), and healthy volunteers (HD, N = 9, filled triangle) cocultured with autologous HIV-infected CD4 + T cells at E:T ratio of 1:1 at day 7. (B) In vitro HIV suppression assay mediated by HIVp24-specific T cell lines from VC (N = 4, filled circle) and NC (N = 7, open rectangle) cocultured with autologous HIV-infected CD4 + T cells at E:T ratio of 1:1 at day 3. (C) Percentages of ex vivo HIV-infected CD4 + T cells (CD3 pos CD8 neg P24 pos ) in VC (N = 8, filled circle) and NC (N = 13, open rectangle) (D) Production of newly-generated HIV from CD4 + T cells from VC (N = 5, filled circle) and NC (N = 5, open rectangle) at day 7. The Y-axis depicts the concentration of HIVp24 Ag (pg/ml) from ELISA assays. *p value <0.05 and ***p value<0.001.
Article Snippet: Twenty-three overlapping
Techniques: In Vitro, HIV Inhibition Assay, Ex Vivo, Infection, Generated, Concentration Assay, Enzyme-linked Immunosorbent Assay
Journal: PLoS ONE
Article Title: Clinical Outcome of HIV Viraemic Controllers and Noncontrollers with Normal CD4 Counts Is Exclusively Determined by Antigen-Specific CD8 + T-Cell-Mediated HIV Suppression
doi: 10.1371/journal.pone.0118871
Figure Lengend Snippet: (A) In vitro HIV suppression assay mediated by ex vivo unstimulated CD8 + T cells in culture with autologous CD4 + T cells at various E:T ratios of 1:1 and 0.5:1 in VC (N = 2, filled circle) and NC (N = 3, open rectangle). (B) In vitro HIV suppression assay mediated by HIVp24-specific T cell lines at various E:T ratios of 1:1 and 0.5:1 in VC (N = 2, filled circle) and NC (N = 2, open rectangle).
Article Snippet: Twenty-three overlapping
Techniques: In Vitro, HIV Inhibition Assay, Ex Vivo